ZNF252P-AS1/miR-324-3p/LY6KKnockdown of ZNF252P-AS1 could restrain tumorigenesis of ovarian cancer in mouse models, which suggested that ZNF252P-AS1 might be considered as a new potential therapeutic target for ovarian cancer. This evidence concerns the gene ZNF252P and ovarian cancer.